Advancing MS Clinical Trials: Integrating Medical Imaging, Precision Motion Analysis, and eCOA Data for Enhanced Outcomes Webinar replay
This webinar provides a retrospective on how advanced technologies have revolutionized Multiple Sclerosis (MS) clinical trials. Discover how the integration of medical imaging, precision motion analysis, and electronic Clinical Outcome Assessment (eCOA) data led to more accurate, reliable, and patient-centered results.
Key topics covered:
- Medical Imaging: Explore the critical role of advanced medical imaging techniques and AI integration in MS trials. Learn about advancements in image analysis and AI-based lesion detection, which enhanced accuracy and efficiency.
- Precision Motion Analysis: Discover how precision motion monitoring, using wearable sensors and algorithms, provided detailed insights into gait, balance, and movement in MS patients. This technology enhanced the ability to determine drug efficacy.
- eCOA: Learn about the transformative impact of high-quality eCOAs on MS trials. Focus on its role in rater qualification, data collection, and review, particularly as it relates to the Expanded Disability Status Scale (EDSS).
Speaker insights:
The speakers reviewed recent studies that demonstrated the practical applications and benefits of integrating these advanced technologies in multiple sclerosis clinical trials. They showcased real-world impacts and advancements in the field.
Key takeaways:
- Learn how AI enhanced image analysis, lesion detection, and predictive modeling for more accurate and efficient MS trials.
- Gain insights into how wearable sensors and algorithms provided detailed assessments of motor function, aiding in intervention evaluation.
- See how a well-executed eCOA strategy enhanced data quality and accuracy, particularly with the Expanded Disability Status Scale (EDSS).
- Review recent studies demonstrating the practical applications and benefits of integrating these technologies in MS clinical trials.
